Free Trial

Precision Optics (POCI) Competitors

Precision Optics logo
$5.23 +0.50 (+10.57%)
(As of 11/15/2024 ET)

POCI vs. STRR, GUTS, SRTS, FONR, EDAP, ECOR, LNSR, TELA, MGRM, and VANI

Should you be buying Precision Optics stock or one of its competitors? The main competitors of Precision Optics include Star Equity (STRR), Fractyl Health (GUTS), Sensus Healthcare (SRTS), FONAR (FONR), Edap Tms (EDAP), electroCore (ECOR), LENSAR (LNSR), TELA Bio (TELA), Monogram Orthopaedics (MGRM), and Vivani Medical (VANI). These companies are all part of the "medical equipment" industry.

Precision Optics vs.

Precision Optics (NASDAQ:POCI) and Star Equity (NASDAQ:STRR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, community ranking, risk, institutional ownership and media sentiment.

Precision Optics has a beta of 0.21, indicating that its stock price is 79% less volatile than the S&P 500. Comparatively, Star Equity has a beta of 0.1, indicating that its stock price is 90% less volatile than the S&P 500.

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 16.3% of Precision Optics shares are owned by company insiders. Comparatively, 33.5% of Star Equity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Precision Optics had 5 more articles in the media than Star Equity. MarketBeat recorded 9 mentions for Precision Optics and 4 mentions for Star Equity. Star Equity's average media sentiment score of 0.70 beat Precision Optics' score of 0.51 indicating that Star Equity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precision Optics
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Star Equity
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Star Equity received 3 more outperform votes than Precision Optics when rated by MarketBeat users. Likewise, 100.00% of users gave Star Equity an outperform vote while only 0.00% of users gave Precision Optics an outperform vote.

CompanyUnderperformOutperform
Precision OpticsOutperform Votes
No Votes
Underperform Votes
2
100.00%
Star EquityOutperform Votes
3
100.00%
Underperform Votes
No Votes

Star Equity has higher revenue and earnings than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than Star Equity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.10M1.74-$2.95M-$0.62-8.44
Star Equity$45.78M0.22$25.13M-$2.79-1.14

Star Equity has a net margin of -14.65% compared to Precision Optics' net margin of -20.01%. Star Equity's return on equity of -5.74% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-20.01% -34.90% -21.55%
Star Equity -14.65%-5.74%-3.34%

Summary

Star Equity beats Precision Optics on 10 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POCI vs. The Competition

MetricPrecision OpticsElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$33.21M$3.61B$5.15B$8.74B
Dividend YieldN/A1.65%5.18%4.08%
P/E Ratio-8.4411.2365.5913.48
Price / Sales1.7499.251,278.7587.67
Price / CashN/A46.1739.7035.24
Price / Book3.153.806.475.93
Net Income-$2.95M$92.21M$119.73M$225.73M
7 Day Performance4.60%-2.39%-5.13%-1.34%
1 Month Performance21.06%13.84%-2.71%1.15%
1 Year Performance-11.05%26.34%31.08%24.02%

Precision Optics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POCI
Precision Optics
0.9129 of 5 stars
$5.23
+10.6%
N/A-12.1%$33.21M$19.10M-8.4480Short Interest ↓
News Coverage
Gap Up
STRR
Star Equity
2.1789 of 5 stars
$3.41
-1.2%
N/A-32.5%$11.01M$45.78M-1.22171Upcoming Earnings
News Coverage
GUTS
Fractyl Health
1.6953 of 5 stars
$2.54
+4.5%
N/AN/A$121.74M$120,000.000.00102Earnings Report
Insider Selling
News Coverage
SRTS
Sensus Healthcare
4.1171 of 5 stars
$6.95
-2.8%
N/A+263.8%$113.91M$24.41M16.9540Analyst Forecast
Analyst Revision
News Coverage
FONR
FONAR
2.3415 of 5 stars
$15.73
+1.9%
N/A-10.7%$99.57M$102.88M10.28480Analyst Downgrade
Short Interest ↓
News Coverage
EDAP
Edap Tms
3.0541 of 5 stars
$2.56
-3.0%
N/A-47.9%$94.99M$62.05M-3.94307
ECOR
electroCore
0.8725 of 5 stars
$13.65
+9.8%
N/A+80.2%$88.04M$16.03M-6.2050Short Interest ↑
Analyst Revision
News Coverage
High Trading Volume
LNSR
LENSAR
3.1336 of 5 stars
$7.09
+0.7%
N/A+237.1%$82.32M$42.16M-4.86110Short Interest ↓
Positive News
Gap Down
TELA
TELA Bio
4.0211 of 5 stars
$3.07
-1.3%
N/A-38.5%$75.86M$58.45M-1.82120Short Interest ↓
MGRM
Monogram Orthopaedics
0.965 of 5 stars
$2.18
-1.8%
N/A-26.0%$75.62M$370,000.00-6.4128Upcoming Earnings
News Coverage
Gap Down
VANI
Vivani Medical
3.1631 of 5 stars
$1.34
+7.2%
N/A+37.9%$74.04MN/A-2.8520Insider Buying
News Coverage

Related Companies and Tools


This page (NASDAQ:POCI) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners